With the cold blast of winter, there is the usual rush of people with asthma wanting their inhalers. It is also a good time to review asthma control and discuss the suitability of the relatively new approach to managing mild asthma
A patient has requested her prescription early. I have never met her, but I can see in her notes that six weeks ago she got them early because she said she had lost all her pills in a waterfall
What is simple irritable bowel syndrome in some patients may change, over years, to become a chronic pain problem unrelated to bowel habit, often with major effects on work, family and social activities, writes gastroenterologist Alan Fraser
This article reviews a mindfulness meditation-based programme that brings cultural and scientific elements together to provide care that is meaningful to Māori
Last year, cilazapril with hydrochlorothiazide was discontinued, and now cilazapril alone is no longer funded for new patients. Consultant cardiologist Chris Ellis discusses what to do when patients with hypertension run out of their supply of these medications
The arrival of funded empagliflozin has been eagerly awaited by many. As you start prescribing it to patients meeting Pharmac’s new Special Authority criteria, here’s a hypothetical case study illustrating one possible adverse effect to be aware of
New oral medicines are showing great promise in slowing down the progression of COVID-19 and preventing the need for intensive medical care, says Ministry of Health chief science advisor Ian Town
Pharmac’s drug buying approach disadvantages Māori, Pacific people, disabled people, those living with rare disorders and does little to reduce inequity.
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management